Author: Nancy Luna

Oncocyte Exits Irvine, Rebrands as Insight Molecular Diagnostics

Oncology diagnostics firm Oncocyte Corp. announced Tuesday a rebranding and relocation of the company’s headquarters from Irvine to Nashville, Tennessee. The rebranded company is now called Insight Molecular Diagnostics Inc. Before the market opens June 18, its common stock (Nasdaq: OCX) will begin to trade under the new Nasdaq ticker, “IMDX.” Read More

Oncocyte Exits Irvine, Rebrands as Insight Molecular Diagnostics

Oncology diagnostics firm Oncocyte Corp. announced Tuesday a rebranding and relocation of the company’s headquarters from Irvine to Nashville, Tennessee. The rebranded company is now called Insight Molecular Diagnostics Inc. Before the market opens June 18, its common stock (Nasdaq: OCX) will begin to trade under the new Nasdaq ticker, “IMDX.” Read More